Suggestions
Sreenivasan (Sreeni) Narayanan
Senior Healthcare Industry Executive | Entrepreneur | Investor | Builder
Sreenivasan (Sreeni) Narayanan is an investor at EarliTec Diagnostics, Inc., where he focuses on identifying and monetizing opportunities within the healthcare sector. His professional background includes extensive experience in technology and business leadership, particularly in the IT industry.
Professional Background
- Experience: Dr. Narayanan has over 30 years of experience in the IT field, with 15 years spent in the USA. He has held various roles that include being a practitioner, architect, consultant, and client partner. His work has involved leading digital transformations and enterprise IT systems for Fortune 1000 companies across multiple continents.12
- Expertise: He specializes in areas such as strategy execution, business transformation, global enterprise service delivery, and technology consulting. His approach often integrates business growth with technology adoption and innovation.12
Education
- Master’s Degree: Physics from IIT Madras.
- MBA: Business Administration from California Coast University.
- Doctorate: PhD in Management Studies from Universidad Azteca.1
Skills and Interests
Dr. Narayanan is passionate about technology and its role in creating disruption and transformation within industries. He is also involved in mentoring and collaboration within technology and startup ecosystems.1
Overall, Sreeni Narayanan combines a strong academic background with extensive practical experience to drive innovation and growth in the healthcare technology space.
Highlights
After an incredible journey with EarliTec Diagnostics, I decided to take a break from my role as the CTO two months ago. It has been an honor and a privilege to lead such a talented and dedicated team, and I am immensely proud of what we have achieved together since June of 2021 at EarliTec.
This decision wasn’t easy, as my time at Earlitec has been filled with invaluable experiences and relationships. Together, we’ve made a significant impact on the early diagnosis & assessment of autism in children as young as 16 months, and I’m deeply grateful for the journey.
These achievements are a testament to the hard work and dedication of everyone at EarliTec. I am grateful for the support of our partners, investors, board members, and the broader Autism community who have shared our vision of transforming Autism diagnosis & assessment. There are too many people to acknowledge, but I do want to thank our founders Ami Klin, PhD & Warren Jones, PhD for their vision and guidance.
I will be announcing my next steps in the near future, and I look forward to sharing this exciting journey with you all.
It’s been a while since I started my role at Centerline Biomedical as an Investor, but I wanted to share this update with everyone.
